KEWAUNEE SCIENTIFIC CORP /DE/
KEWAUNEE SCIENTIFIC CORP /DE/
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 10 | 8 | 13 | 19 | 15 | 9 | 26 | 24 | 23 | 21 | 14 | 13 | |||||
Restricted Cash And Cash Equivalents At Carrying V… | 2 | 2 | 1 | 1 | 2 | 3 | 4 | 1 | 3 | 6 | 8 | 9 | |||||
Accounts Receivable Net Current | 59 | 54 | 59 | 57 | 62 | 57 | 42 | 44 | 45 | 41 | 43 | 42 | |||||
Inventory Net | 31 | 33 | 35 | 35 | 33 | 32 | 19 | 19 | 21 | 22 | 22 | 22 | |||||
Prepaid Expense And Other Assets Current | 5 | 6 | 5 | 5 | 6 | 7 | 6 | 5 | 5 | 6 | 5 | 7 | |||||
Assets Current | 105 | 104 | 114 | 117 | 118 | 109 | 96 | 93 | 97 | 96 | 91 | 94 | |||||
Property Plant And Equipment Gross | - | 75 | 74 | 73 | - | 73 | 65 | 64 | - | 64 | 64 | 63 | |||||
Accumulated Depreciation Depletion And Amortizatio… | - | -52 | -51 | -50 | - | -49 | -48 | -47 | - | -47 | -46 | -46 | |||||
Property Plant And Equipment Net | 22 | 23 | 23 | 23 | 23 | 24 | 17 | 17 | 18 | 17 | 18 | 17 | |||||
Operating Lease Right Of Use Asset | 11 | 10 | 11 | 12 | 13 | 14 | 7 | 7 | 7 | 8 | 8 | 9 | |||||
Deferred Income Tax Assets Net | 4 | 4 | 4 | 4 | 4 | 4 | 8 | 8 | 7 | - | - | - | |||||
Intangible Assets Net Excluding Goodwill | 16 | 17 | 17 | 17 | 18 | 18 | - | - | 0 | - | - | - | |||||
Goodwill | 12 | 12 | 12 | 12 | 12 | 14 | - | - | 0 | - | - | - | |||||
Other Assets Noncurrent | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 7 | 5 | 5 | 5 | 5 | |||||
Assets | 178 | 176 | 189 | 193 | 195 | 189 | 134 | 132 | 135 | 126 | 122 | 125 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Short Term Borrowings | 0 | - | - | - | 1 | - | - | - | 3 | - | - | - | |||||
Secured Debt Current | 5 | 5 | 3 | 3 | 3 | 3 | - | - | 0 | - | - | - | |||||
Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Accounts Payable Current | 22 | 24 | 23 | 26 | 27 | 25 | 21 | 21 | 23 | 19 | 19 | 22 | |||||
Employee Related Liabilities Current | 9 | 7 | 8 | 8 | 9 | 7 | 4 | 3 | 6 | 6 | 5 | 5 | |||||
Contract With Customer Liability Current | 4 | 4 | 4 | 5 | 6 | 8 | 6 | 5 | 4 | 10 | 5 | 7 | |||||
Other Accrued Liabilities Current | 3 | 3 | 3 | 4 | 3 | 3 | 1 | 2 | 1 | 1 | 1 | 2 | |||||
Liabilities Current | 48 | 49 | 46 | 50 | 54 | 50 | 36 | 37 | 41 | 42 | 39 | 44 | |||||
Long Term Notes Payable | 0 | 0 | 23 | 24 | 24 | 23 | - | - | 0 | - | - | - | |||||
Secured Long Term Debt | 15 | 16 | 9 | 10 | 10 | 12 | - | - | 0 | - | - | - | |||||
Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 6 | 6 | 7 | 8 | 9 | 10 | 5 | 5 | 5 | 6 | 6 | 7 | |||||
Deferred Income Tax Liabilities Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 101 | 103 | 117 | 125 | 128 | 127 | 74 | 75 | 79 | 81 | 78 | 84 | |||||
Stockholders Equity Inclu… | |||||||||||||||||
Common Stock Value | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | |||||
Additional Paid In Capital Common Stock | 7 | 7 | 6 | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Retained Earnings Accumulated Deficit | 69 | 65 | 64 | 62 | 59 | 54 | 53 | 50 | 48 | 36 | 34 | 31 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -5 | -5 | -4 | -4 | -4 | -4 | -4 | -3 | -3 | -4 | -4 | -4 | |||||
Treasury Stock Common Value | -4 | -4 | -4 | -4 | -4 | -2 | -2 | -2 | -2 | -1 | -0 | -0 | |||||
Stockholders Equity | 75 | 73 | 70 | 67 | 64 | 61 | 61 | 56 | 55 | 44 | 43 | 39 | |||||
Minority Interest | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities And Stockholders Equity | 178 | 176 | 189 | 193 | 195 | 189 | 134 | 132 | 135 | 126 | 122 | 125 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Common Stock Par Or Stated Value Per Share | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | 2.5 | |||||
Common Stock Shares Authorized | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Common Stock Shares Issued | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Shares Outstanding | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 1.11% | -1.34% | -12.20% | -0.74% | 4.66% | 9.82% | -3.49% | 7.04% | 15.12% | 6.39% | - | - |
| 2025 | -14.32% | -0.41% | 13.00% | 16.13% | 20.43% | 1.82% | -25.03% | -33.80% | -19.17% | 2.22% | 0.19% | -23.54% |
| 2024 | -1.08% | 5.05% | 4.65% | 31.54% | 31.45% | 29.28% | 18.54% | 20.26% | 40.97% | 7.73% | 3.77% | -21.76% |
| 2023 | - | - | - | - | - | - | - | - | - | -3.23% | -0.20% | 22.77% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | 2023-07-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 2.18 | 2.12 | 2.48 | 2.32 | 2.20 | 2.16 | 2.64 | 2.53 | 2.37 | 2.28 | 2.35 | 2.11 | |||||
| Quick Ratio | 1.46 | 1.32 | 1.59 | 1.53 | 1.48 | 1.39 | 1.96 | 1.87 | 1.74 | 1.62 | 1.66 | 1.45 | |||||
| Working Capital | 57.05M | 54.79M | 67.83M | 66.66M | 64.65M | 58.44M | 59.97M | 56.01M | 56.04M | 54.01M | 52.14M | 49.29M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 1.36 | 1.43 | 1.68 | 1.86 | 1.99 | 2.09 | 1.22 | 1.33 | 1.43 | 1.84 | 1.80 | 2.14 | |||||
| Interest Coverage TTM | 3.40 | 4.11 | 4.02 | 4.68 | 4.82 | 5.62 | 8.57 | 9.26 | 10.16 | 8.78 | 7.81 | 5.38 | |||||
| Debt Ratio | 0.57 | 0.59 | 0.62 | 0.64 | 0.66 | 0.67 | 0.55 | 0.56 | 0.58 | 0.64 | 0.64 | 0.68 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 1.51 | 1.58 | 1.76 | 1.62 | 1.46 | 1.39 | 1.56 | 1.58 | 1.61 | 1.62 | 1.79 | 1.75 | |||||
| Days Sales Outstanding TTM | 78.39 | 70.75 | 64.50 | 69.65 | 81.54 | 81.72 | 77.23 | 77.58 | 81.64 | 77.25 | 71.34 | 69.25 | |||||
| Receivables Turnover TTM | 4.66 | 5.16 | 5.66 | 5.24 | 4.48 | 4.47 | 4.73 | 4.70 | 4.47 | 4.72 | 5.12 | 5.27 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 3.51 | 3.74 | 3.96 | 4.15 | 3.83 | 5.84 | 6.27 | 6.23 | 6.38 | 3.13 | 2.56 | 1.58 | |||||
| Free Cash Flow Per Share TTM | 5.13 | 6.65 | 1.79 | 6.56 | 4.41 | 1.36 | 5.53 | 2.67 | 5.28 | 4.22 | -0.15 | -1.65 | |||||
| Dividend Per Share TTM | 0.12 | 0.15 | 0.03 | 0.09 | 0.09 | 0.06 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 28.52% | 28.93% | 29.09% | 29.37% | 28.63% | 27.02% | 26.60% | 26.01% | 25.55% | 23.76% | 21.42% | 18.84% | |||||
| Operating Profit Margin TTM | 5.93% | 6.95% | 6.89% | 7.60% | 7.39% | 6.73% | 8.20% | 8.43% | 8.97% | 7.67% | 6.47% | 4.36% | |||||
| Net Profit Margin TTM | 3.71% | 3.88% | 4.14% | 4.68% | 4.74% | 7.95% | 9.35% | 9.13% | 9.20% | 4.62% | 3.49% | 2.08% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 17.27% | 30.78% | 43.02% | 30.09% | 18.02% | 9.44% | -7.18% | -7.71% | -7.17% | -6.59% | 10.28% | 22.12% | |||||
| Net Income Growth (1Y) | -8.24% | -36.16% | -36.60% | -33.39% | -39.18% | 88.19% | 148.89% | 305.80% | 1,279.91% | -2,501.55% | -408.60% | -184.06% | |||||
| EPS Growth (1Y) | -8.27% | -36.02% | -36.47% | -33.43% | -38.82% | 89.56% | 151.58% | 307.37% | 1,253.55% | -2,449.25% | -400.84% | -182.50% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 10.13 | 10.15 | 10.13 | 12.82 | 7.95 | 10.56 | 4.88 | 8.58 | 5.48 | 8.76 | 7.07 | 9.84 | |||||
| P/B TTM | 1.42 | 1.56 | 1.72 | 2.35 | 1.41 | 3.04 | 1.50 | 2.83 | 1.88 | 1.85 | 1.22 | 1.14 | |||||
| P/S TTM | 0.38 | 0.39 | 0.42 | 0.60 | 0.38 | 0.84 | 0.46 | 0.78 | 0.50 | 0.40 | 0.25 | 0.20 | |||||
| Market Cap | 105.96M | 113.32M | 119.86M | 157.77M | 90.64M | 184.67M | 91.10M | 158.46M | 102.78M | 81.41M | 52.98M | 44.79M | |||||
| Enterprise Value | 114.47M | 124.26M | 141.11M | 174.17M | 111.56M | 210.55M | 61.70M | 133.61M | 80.29M | 54.65M | 31.64M | 23.45M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 14.70M | 19.06M | 5.12M | 18.71M | 12.62M | 3.89M | 15.87M | 7.60M | 15.19M | 12.20M | -433.00K | -4.72M | |||||
| Net Debt | 8.51M | 10.94M | 21.25M | 16.40M | 20.92M | 25.88M | -29.40M | -24.85M | -22.49M | -26.76M | -21.34M | -21.34M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) — SEC Financial Statements & Analysis
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) is a laboratory apparatus & furniture company, incorporated in DE. KEWAUNEE SCIENTIFIC CORP /DE/ trades on Nasdaq as: KEQU. Based on its latest SEC filing (Form 10-Q, period ending 2026-04-30), KEWAUNEE SCIENTIFIC CORP /DE/ reported a 17.27% year-over-year revenue growth, a Gross Profit Margin of 28.52% (TTM), a Debt-to-Equity ratio of 1.36x, a Price-to-Sales (P/S) ratio of 0.38x (TTM), a Price-to-Book (P/B) ratio of 1.42x (TTM), at a market cap of $105.96M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 17.27%
- Gross Profit Margin TTM
- 28.52%
- Debt To Equity
- 1.36x
- P/S TTM
- 0.38x
- P/B TTM
- 1.42x
- Market Cap
- $105.96M
Data as of 2026-04-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is KEWAUNEE SCIENTIFIC CORP /DE/ in?
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) operates in the Laboratory Apparatus & Furniture industry.
What is KEQU's market cap?
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) has a market capitalization of $105.96M as of 2026-04-30.
What is KEQU's P/E ratio?
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)'s trailing twelve month P/E ratio is 10.13x as of 2026-04-30.
What exchange does KEQU trade on?
KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU) trades on the Nasdaq.
Where is KEWAUNEE SCIENTIFIC CORP /DE/ incorporated?
KEWAUNEE SCIENTIFIC CORP /DE/ is incorporated in DE.